The shares trade with liquidity of less than $1 million per day, while Schott AG retains a 77% stake. RBC applied a 9x 2027E EBITDA multiple, incorporating a 15% liquidity discount and 10% discount ...

BioNTech SE ( ($BNTX) ) has issued an update. On December 3, 2025, BioNTech SE announced that it has satisfied the minimum condition of its ...

The long-anticipated merger between Germany's leading mRNA developers is now official. BioNTech SE announced late Wednesday ...

Stocks closed higher Tuesday, a day after the three major equities indexes ended their runs of five consecutive winning sessions.

Vertex Pharmaceuticals Incorporated VRTX stock has risen 9.2% in the past three months. However, the stock has significantly ...

VAERS, the Vaccine Safety Datalink, clinical investigators in the U.S. and their European counterparts detected that these vaccines did turn out to cause blood clotting. In April 2021, the FDA ...

The minimum condition for the offer has been satisfied, with 184,071,410 shares of CureVac, representing approximately 81.74% of CureVac’s issued ...

Vertex Pharmaceuticals Incorporated ( VRTX) Citi Annual Global Healthcare Conference 2025 December 3, 2025 9:00 AM EST ...

A dozen former FDA commissioner say proposed FDA vaccine approval changes could impact public health, innovation, and biotech costs. Read more here.

A major German biotech deal neared completion on Wednesday with the takeover bid by BioNTech being accepted by a large ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced changes to its Board of Directors, including the departure of two directors and the appointment of ...